Regulatory and Commercial Research    

Jouhou Koukai Services LLC and its businesses provide information and intelligence on the Japanese pharmaceutical market in the fields of drug and medical device approval, regulatory and pharmaceutical affairs, and market data.

Company of the week: Banyu Seiyaku KK

Banyu Seiyaku KK office building in Tokyo

 

Regulatory and Commercial Headlines

JKS News: XML  RSS feed

●February 1, 2010: JKS News: PMDA PMDA Headoffice in TokyoPMDA Headoffice in Tokyo updates the comprehensive information on quasi-drug regulations, including the draft requirements for the raw ingredients ... OTC, BTC and quasi-drug consulting services
●January 25, 2010: Diabetes news: Banyu Seiyaku KK Banyu Seiyaku KK office building in TokyoBanyu Seiyaku KK office building in Tokyo , a Merck &C. group company buoyed by the prospects for the first-of-class DPP-4 (dipeptidyl peptidase IV) inhibitor Januvia (sitagliptin) in the diabetes market in Japan, projected to grow by 50% by 2017 to 377 billion Yen ... Anti-diabetes products in JAD Databases | Metabolic Syndrome report preview | Epidemiology of diabetes data
●January 21, 2010: Flu pandemic in Japan update (8) - vaccine glut: The MHLW MHLW Headoffice in TokyoMHLW Headoffice in Tokyo approved the use, but may cancel part of the purchase contract for 9.9 million doses of foreign-made anti-H1N1 vaccines (7.4 million doses of Pandemrix and 2.5 million doses of Celtura) after only one prefecture in Japan requested just 200 doses of products imported by the domestic subsidiaries of by Britain's GlaxoSmithKline PLC GSK headoffice in TokyoGSK headoffice in Tokyo and Switzerland's Novartis AG Novartis Pharma KK logoNovartis Pharma KK logo ; the distribution of the imported vaccines - made by using cell cultures and containing no unapproved adjuvant (MF59) to start in February as 10,000-subject PMS is scheduled to offset the limitation of emergency 100-subject pre-approval trial; the National Institute of Infectious Diseases (NIID) NIIDNIID estimated the number of infected to have reached 19.23 millions ... Anti-flu products in JAD Databases | Epidemiology consulting and data


... all headline news

DOCUMENTS STORE

PDF Document Japan Master Files - view

PDF Document Accredited Foreign Manufacturers preview

PDF Document Japan Orphan Drugs
preview

PDF Document Japan Pricing & Reimbursement preview

PDF Document Japanese Generics and API
preview

PDF Document Stigmatized Markets: ED
preview

PDF Document Stigmatized Markets: Depression preview

PDF Document Stigmatized Markets: Genital Herpes preview

PDF Document Stigmatized Markets: Metabolic Syndrome preview

PDF Document Unapproved Medicinal Products (drug lag) preview

PDF Document Vaccines and Sera (vaccine gap) preview

READING ROOM

New free resources

MEDIA & NEWS

EContent Magazine: Jouhou Koukai Adds to Database

 

Jouhou Koukai Services LLC
The main information services and B2B e-commerce site of the Jouhou Koukai Services LLC - the leading provider of pharmaceutical development, regulatory and business intelligence information on the Japanese pharma and medical device market. The site contains the only English-language database of medicinal products approved in Japan from 1999 until present (Japan Approvals Database, JAD), free information resources and the online JKS Document Store (e-documents and e-books). Linked are the sites of the key businesses of JKS - primary market research (www.licenscape.com) and ehealth (www.ehealth-japan.com).